Skip to main content
. 2023 Jul 12;14:1218679. doi: 10.3389/fphar.2023.1218679

TABLE 1.

List of drug names and adverse drug events. We used all possible mentions of these drugs and ADEs in our study.

Drug ADE
Atezolizumab Colitis
Ipilimumab Pneumonitis
Nivolumab Thyroid
Pembrolizumab Abnormalities
Tremelimumab Rash/dermatitis
Avelumab Hepatitis
Durvalumab Myalgia/arthralgia
Cemiplimab Cardiotoxicity